Literature DB >> 2176900

Inhibition of coagulation and platelet adhesion to extracellular matrix by unfractionated heparin and a low molecular weight heparin.

K Krupinski1, M Basic-Micic, E Lindhoff, H K Breddin.   

Abstract

In 7 healthy volunteers, the effect of a single i.v. injection of 52 mg (7,500 IU) of an unfractionated heparin (UFH) and of 52.5 mg (5,000 anti XaU) of a low molecular weight heparin (LMWH) on coagulation parameters and platelet function has been studied. Thrombin-induced platelet aggregation was inhibited after the injection of both heparins. There was no significant change of ADP or collagen-induced aggregation after LMWH of UFH. Platelet adhesion to bovine extracellular matrix was not inhibited by UFH but was significantly reduced after addition in vitro and ex vivo after administration of LMWH. Further investigation should establish the time course of LMWH effects on platelet adhesion. A long duration of this effect could be partially correlated with the antithrombotic effects of LMWH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176900     DOI: 10.1007/BF01732879

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  22 in total

1.  On the measurement of spontaneous platelet aggregation. The platelet aggregation test III. Methods and first clinical results.

Authors:  K Breddin; H Grun; H J Krzywanek; W P Schremmer
Journal:  Thromb Haemost       Date:  1976-06-30       Impact factor: 5.249

2.  Comparison of the platelet pro-aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222).

Authors:  M A Barradas; D P Mikhailidis; O Epemolu; J Y Jeremy; V Fonseca; P Dandona
Journal:  Br J Haematol       Date:  1987-12       Impact factor: 6.998

3.  The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo.

Authors:  C Thomson; C D Forbes; C R Prentice
Journal:  Clin Sci Mol Med       Date:  1973-10

4.  An objective assessment of the interaction of heparin and its fractions with human platelets.

Authors:  L D Brace; J Fareed
Journal:  Semin Thromb Hemost       Date:  1985-04       Impact factor: 4.180

5.  Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina.

Authors:  I Vlodavsky; A Eldor; E HyAm; R Atzom; Z Fuks
Journal:  Thromb Res       Date:  1982-10-15       Impact factor: 3.944

6.  In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets.

Authors:  H L Messmore; B Griffin; J Fareed; E Coyne; J Seghatchian
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

Review 7.  Effect of heparin and heparin fractions on platelet aggregation.

Authors:  E W Salzman; R D Rosenberg; M H Smith; J N Lindon; L Favreau
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

8.  Comparative study on the in vitro and in vivo activities of seven low-molecular-weight heparins.

Authors:  J Fareed; J M Walenga; D Hoppensteadt; X Huan; A Racanelli
Journal:  Haemostasis       Date:  1988

9.  Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously.

Authors:  D Bergqvist; U Hedner; E Sjörin; E Holmer
Journal:  Thromb Res       Date:  1983-11-15       Impact factor: 3.944

10.  In vivo effects of a low molecular weight heparin fragment on platelet aggregation and platelet dependent hemostasis in dogs.

Authors:  B Ljungberg; H Johnsson
Journal:  Thromb Haemost       Date:  1988-10-31       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.